skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine (Code C78193)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine

Definition: A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.

Label: Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine

NCI Thesaurus Code: C78193 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL383583  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Autologous Dinitrophenyl-Modified Ovarian Cancer Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 595043
PDQ Open Trial Search ID 595043 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C78193
Legacy_Concept_Name Autologous_Dinitrophenyl-Modified_Ovarian_Cancer_Vaccine
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom